Loading…
Fierce Virtual Series: JPM Week 2021 has ended

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Monday, January 11
 

9:30am EST

Open for Networking
Monday January 11, 2021 9:30am - 10:00am EST

10:00am EST

In-Development COVID-19 Therapeutics
What are the most promising therapeutics coming up through biopharma's pipelines? How can pharma improve on those therapeutics currently in use under emergency authorizations? What role will combinations play, and which mechanisms of action might pair well together? How many opportunities will be left for therapeutic makers after vaccines take hold? Which companies are looking to treat COVID's long-lasting effects (lung damage, kidney damage etc.) and how?

Moderator
avatar for Amirah Al Idrus

Amirah Al Idrus

Editor, Fierce Biotech

Speakers
avatar for Julie Kim

Julie Kim

President of the Plasma-Derived Therapies Business Unit, Takeda
Julie Kim is the President of the Plasma-Derived Therapies Business Unit for Takeda, responsible for building a sustainable, high growth business focused on meeting the large and growing demand for plasma-derived products, essential for effectively treating patients with a variety... Read More →
avatar for Levi Garraway, M.D., Ph.D.

Levi Garraway, M.D., Ph.D.

Chief Medical Officer, Roche and Genentech
Levi Garraway, M.D., Ph.D., was appointed Chief Medical Officer and Executive Vice President, Head of Global Product Development for Roche and Genentech in October 2019. He leads employees in the Product Development organization across the globe, oversees all aspects of late stage... Read More →
avatar for Ann Leen, Ph.D.

Ann Leen, Ph.D.

Chief Scientific Officer, AlloVir
Dr. Ann Leen is co-founder/CSO at AlloVir. She has seven+ years of industry experience and >20 years of basic and translational science experience in academia. She is based at the Center for Cell and Gene Therapy at Baylor where she serves as Professor, Pediatrics. She has developed... Read More →
avatar for Wendy Holman

Wendy Holman

CEO and Founder, Ridgeback Biotherapeutics
avatar for Karen Flynn

Karen Flynn

Chief Commercial Officer & President, Biologics, Catalent
Karen Flynn was named President, Biologics and Chief Commercial Officer in 2020. Prior to joining Catalent, she served as the Senior Vice President and Chief Commercial Officer of West Pharmaceutical Services, Inc. from 2016 to 2019, having previously served as that company’s President... Read More →


Monday January 11, 2021 10:00am - 10:45am EST

10:45am EST

Support for the Biotech Journey from Discovery to Commercialization
A biotechnology company faces myriad challenges in its quest to successfully develop and commercialize novel therapies and diagnostics that improve health outcomes. These include economic pressure to wisely utilize invested funding, time pressure to be the first to market with a breakthrough therapy or diagnostic, and quality/compliance pressure to navigate a global and dynamic regulatory environment.  
 
This presentation will provide a brief overview of how to incorporate technology, products, software, and services to help biotech companies across the entire drug development continuum. In addition, we'll provide examples of best practices and case studies of biotech companies’ experience working with a supplier partner as they navigate the complex path to market.

Speakers
avatar for Matt Dunleavy

Matt Dunleavy

Director of Commercial Strategy for Biosciences, Thermo Fisher Scientific
Matt Dunleavy is Director of Commercial Strategy for Biosciences at Thermo Fisher Scientific.  At Thermo Fisher since 2007, he has also held commercial and marketing roles in Laboratory Equipment and Corporate Accounts.  Earlier, at Millipore, U.S. Filter and W.R. Grace, he was... Read More →


Monday January 11, 2021 10:45am - 11:15am EST

11:15am EST

Executive Interview: Daphne Koller, CEO, insitro
Moderator
avatar for Amirah Al Idrus

Amirah Al Idrus

Editor, Fierce Biotech

Speakers
avatar for Daphne Koller

Daphne Koller

CEO and Founder, insitro
Daphne Koller is CEO and Founder of insitro, a company applying machine learning to drug development. Daphne was a Computer Science Professor at Stanford, co-founder and co-CEO of Coursera, and Chief Computing Officer of Calico. Daphne was one of TIME Magazine’s 100 most influential... Read More →


Monday January 11, 2021 11:15am - 11:30am EST

11:30am EST

Executive Interview: Samit Hirawat, M.D., Chief Medical Officer, Bristol Meyers Squibb
Moderator
avatar for Amirah Al Idrus

Amirah Al Idrus

Editor, Fierce Biotech

Speakers
avatar for Samit Hirawat, M.D.

Samit Hirawat, M.D.

Chief Medical Officer, Bristol Myers Squibb
As Chief Medical Officer, Global Drug Development, Dr. Samit Hirawat oversees late-stage product development across all therapeutic areas. In this role, Samit and his organization focus on enabling the rapid progression and delivery of late-stage assets, from proof-of-concept to commercialization... Read More →


Monday January 11, 2021 11:30am - 11:50am EST

12:00pm EST

Networking Break
Monday January 11, 2021 12:00pm - 1:00pm EST

1:00pm EST

Progressing from traditional clinical trials model to pharmacist-led, hybrid model based on A.I. and service subscription
A global network of community pharmacists enhancing the recruitment, dispensing and patient counseling, driving significant time and cost savings while making clinical trials a viable healthcare option for Everyone, Everywhere. 

Speakers
avatar for Yaniv Zilberman

Yaniv Zilberman

CEO, Habitu
Yaniv has 20 years in executive roles, in leading enterprise software solutions, with vast experience in building innovative, technology-based organizations for scale and accelerated growth.Before founding Habitu, Yaniv led large global Professional Services organizations (Pontis... Read More →
avatar for Gerald E. Finken, RPh

Gerald E. Finken, RPh

CEO & Founder, RxE2
Gerald is a licensed pharmacist with almost 40 years of experience in the biotechnology and pharmaceutical industries. In 1997, he founded CSM, a clinical supplies packaging and labeling company, where he invented On-Demand packaging and labeling, Clinical Trial Research Pharmacist... Read More →


Monday January 11, 2021 1:00pm - 1:30pm EST

1:30pm EST

Executive Interview: Marianne De Backer, PhD, MBA at Bayer Pharmaceuticals and Pascal Touchon, President and Chief Executive Officer, Atara Biotherapeutics
Moderator
avatar for Rebecca Willumson

Rebecca Willumson

Vice President & Publisher, Fierce Pharma & Fierce Healthcare
Rebecca Willumson is the Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of Fierce Biotech, Fierce Pharma and Fierce Healthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital publications... Read More →

Speakers
avatar for Pascal Touchon

Pascal Touchon

President and Chief Executive Officer, Atara Biotherapeutics
With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon joined Atara Biotherapeutics as President, Chief Executive Officer and member of the Board of Directors in 2019. Pascal is thrilled to lead Atara, as he fully aligns with our mission of delivering... Read More →
avatar for Marianne De Backer, Ph.D., MBA

Marianne De Backer, Ph.D., MBA

Member of the Bayer AG Pharmaceuticals Executive Committee & Executive Vice President and Head of Strategy, Business Development & Licensing, Bayer Pharmaceuticals
Marianne De Backer, MSc, PhD, MBA is EVP of strategy, Business Development & Licensing and member of the Executive Committee of Bayer Pharmaceuticals. She has been a trusted strategic advisor, science and business leader, deal maker and corporate investor in healthcare for... Read More →


Monday January 11, 2021 1:30pm - 2:00pm EST

2:00pm EST

Data driven clinical solutions to enhance cancer patient outcomes
The TD2/VieCure partnership offers enhanced clinical decision making and accelerated therapeutic development processes to community oncology practice with incomparable outcomes. TD2 is a precision medicine therapeutic development company with an enabled early development community oncology practice research network. The VieCure platform is a next generation oncology clinical decision-support system that combines an A.I. clinical inference engine, clinical pathways and an integrated EMR to support personalized treatment planning. The Partnership offers access to real-time, de-identified patient data to assist with site selection, feasibility, and patient identification as well as improved protocol design. Together, the combined capabilities create the foundation for a precision medicine program in the oncology community setting that delivers early responses to clinical trial targets leading to accelerated approvals of a range of therapeutics and patient access to life-saving therapies.

Speakers
avatar for Fred Ashbury, Ph.D.

Fred Ashbury, Ph.D.

Chief Scientific Officer, VieCure
Fred is a co-founder and Chief Scientific Officer at VieCure. He is responsible for developing and maintaining VieCure’s oncology clinical content, genomic-science knowledge identification and codification, and the design and implementation of the treatment strategy rules that underpin... Read More →
avatar for Susan S. Night

Susan S. Night

Vice President, Site Engagement and Network Strategy, TD2
Susan S. Night, JD, LLM is Vice President of Site Engagement and Network Strategy for Translational Drug Development (TD2), a precision oncology CRO. Before joining TD2, Ms Night served as Director, Research Optimization for US Oncology Research/McKesson Specialty Health. She started... Read More →


Monday January 11, 2021 2:00pm - 2:30pm EST

2:30pm EST

Networking Break
Monday January 11, 2021 2:30pm - 3:00pm EST

3:00pm EST

Executive Interview: Mike Riley, Region President, North America, Catalent Biologics
Moderator
avatar for Rebecca Willumson

Rebecca Willumson

Vice President & Publisher, Fierce Pharma & Fierce Healthcare
Rebecca Willumson is the Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of Fierce Biotech, Fierce Pharma and Fierce Healthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital publications... Read More →

Speakers
avatar for Mike Riley

Mike Riley

Region President, North America, Catalent Biologics
Mike Riley is the Regional Biologics President for North America and has overall responsibility for strategy and management of the biologics business in North America. Previously, he served as Vice President/General Manager of Catalent Biologics for five years. Mike has 15 years of... Read More →


Monday January 11, 2021 3:00pm - 3:15pm EST

3:15pm EST

Executive Interview: Alexander Hardy, CEO, Genentech
Moderator
avatar for Carly Helfand

Carly Helfand

Executive Editor, Fierce Pharma
Carly Helfand is a news editor with FierceMarkets' Life Sciences group, writing for FierceVaccines, FiercePharma and FiercePharmaMarketing. Carly got her start covering pharma while earning her master's at Northwestern University's Medill School of Journalism, where she concentrated... Read More →

Speakers
avatar for Alexander Hardy

Alexander Hardy

CEO, Genentech
Alexander Hardy is the CEO of Genentech, a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Alexander has dedicated his career to delivering on the promise of what science can... Read More →


Monday January 11, 2021 3:15pm - 3:35pm EST

3:35pm EST

Executive Interview: Ariel Katz, CEO & Co-Founder, H1
Speakers
avatar for Rebecca Willumson

Rebecca Willumson

Vice President & Publisher, Fierce Pharma & Fierce Healthcare
Rebecca Willumson is the Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of Fierce Biotech, Fierce Pharma and Fierce Healthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital publications... Read More →
avatar for Ariel Katz

Ariel Katz

Co-Founder and CEO, H1
Ariel Katz started his first company in college, ResearchConnection, to help connect students with research opportunities. That company grew to over 40 universities and was eventually acquired by the Jefferson Accelerator Fund, Bill and Melinda Gates Foundation and the Ewing Kauffman... Read More →


Monday January 11, 2021 3:35pm - 3:45pm EST

3:45pm EST

How responses to the 2020 pandemic could underpin accelerated improvements in patient care
In 2020, the life sciences sector mobilized at unprecedented speed to tackle the most significant health crisis facing humanity in a century. Researchers, industry and regulators collaborated to harness innovative science with some creative deal structures to develop treatments and vaccines in record time, clinicians adopted new approaches to consult and treat patients, greater sums of money, from both public and private sources, have been invested to finance these efforts. Clarivate’s Sarah Hardison and Mike Ward will discuss what lessons can be learnt that could accelerate the development of treatments for other major diseases and improve patient care.

Speakers
avatar for Mike Ward

Mike Ward

Global Head of Thought Leadership, Clarivate
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both an award-winning journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial... Read More →
avatar for Sarah Hardison, Ph.D.

Sarah Hardison, Ph.D.

Head of Product, Regulatory & PV, Clarivate
Dr. Sarah Hardison, PhD is Head of Product, Regulatory & PV at Clarivate. Prior to joining Clarivate, Sarah worked in Product and Portfolio Management in Life Sciences companies, building great products to enable drug development pipelines. Sarah earned her PhD in Immunology... Read More →


Monday January 11, 2021 3:45pm - 4:15pm EST

4:15pm EST

Executive Interview: Sean Bohen, CEO, Olema Oncology
Moderator
avatar for Amirah Al Idrus

Amirah Al Idrus

Editor, Fierce Biotech

Speakers
avatar for Sean Bohen, M.D., Ph.D.

Sean Bohen, M.D., Ph.D.

Chief Executive Officer, Olema Oncology
Sean P. Bohen, M.D., Ph.D., is Chief Executive Officer of Olema Oncology. Dr. Bohen has extensive oncology drug development experience, having served as Executive Vice President, Global Medicines Development, and Chief Medical Officer at AstraZeneca PLC. Before that, he held senior... Read More →


Monday January 11, 2021 4:15pm - 4:30pm EST
 
Tuesday, January 12
 

9:30am EST

Open for Networking
Tuesday January 12, 2021 9:30am - 10:00am EST

10:00am EST

"Second-Wave" COVID-19 Vaccines
Moderator
avatar for Eric Sagonowksy

Eric Sagonowksy

Editor, Fierce Pharma
Eric Sagonowsky is an editor with the FierceMarkets Life Sciences team. Before joining Fierce in November 2014, Eric worked as a news reporter for the Manistee News Advocate in Manistee, Mich., covering government and crime issues. Eric graduated from Ohio University's E.W. Scripps... Read More →

Speakers
avatar for Swati Gupta

Swati Gupta

Vice President and Head of Emerging Infectious Diseases and Scientific Strategy, IAVI
Swati Gupta, DrPH, MPH, leads IAVI’s Emerging Infectious Disease product portfolio and the development of the organization’s overall scientific strategy. She has a particular focus in leveraging IAVI’s recombinant vesicular stomatitis virus (rVSV) platform and expertise to expand... Read More →
avatar for Nathalie Landry

Nathalie Landry

Executive Vice President, Scientific and Medical Affairs, Medicago
Nathalie Landry is a dynamic biotech leader with more than 25 years of experience leading teams and programs to successful milestones. At Medicago, she oversees a multidisciplinary team in charge of research and development (R&D), product development, analytical development, process... Read More →
avatar for Thomas Lingelbach

Thomas Lingelbach

President and CEO, Valneva
Previous CEO of Intercell, Managing Director for Novartis Vaccines & Diagnostics Germany, Vice President of Global Industrial Operations at Chiron Vaccines, more than 25 years in the vaccine industry.  
avatar for Paul Stoffels, M.D.

Paul Stoffels, M.D.

Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson
Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of people around the world. Paul spearheads the Johnson & Johnson research and product pipeline by leading teams across all our sectors... Read More →
avatar for Ricci Whitlow

Ricci Whitlow

President, Clinical Supply Services, Catalent
Ricci Whitlow was named President, Clinical Supply Services in January 2020. She rejoins Catalent after two-and-a-half years, having previously held the position of VP Operations, overseeing nine manufacturing facilities across North and South America. Her most recent position was... Read More →


Tuesday January 12, 2021 10:00am - 10:50am EST

10:50am EST

Innovating in a Crisis
During this keynote section Martin Meeson, the Chief Executive Officer at FUJIFILM Diosynth Biotechnologies' will address the role of innovation in the Contract Development and Manufacturing space, and the biopharmaceutical industry as a whole, during the COVID-19 pandemic. What is innovation and why do we innovate?

Speakers
avatar for Martin Meeson

Martin Meeson

Chief Executive Officer, FUJIFILM Diosynth Biotechnologies
Martin Meeson is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets. Martin was named Chief Executive Officer on April 1st, 2020 after serving as Chief Operating Officer and President at of our US FDB operations (North Carolina... Read More →


Tuesday January 12, 2021 10:50am - 11:15am EST

11:15am EST

Executive Interview: Ruud Dobber, Executive Vice President and President, BioPharmaceuticals Business Unit, AstraZeneca
Moderator
avatar for Carly Helfand

Carly Helfand

Executive Editor, Fierce Pharma
Carly Helfand is a news editor with FierceMarkets' Life Sciences group, writing for FierceVaccines, FiercePharma and FiercePharmaMarketing. Carly got her start covering pharma while earning her master's at Northwestern University's Medill School of Journalism, where she concentrated... Read More →

Speakers
avatar for Ruud Dobber

Ruud Dobber

EVP and President, BioPharmaceuticals Business Unit, AstraZeneca
Ruud Dobber was appointed Executive Vice President (EVP) and President, BioPharmaceuticals Business Unit in January 2019 and is responsible for product strategy and commercial delivery for Cardiovascular, Renal & Metabolism (CVRM) and Respiratory diseases.  Prior to this, Ruud held... Read More →


Tuesday January 12, 2021 11:15am - 11:30am EST

11:30am EST

Optimizing Successful Commercialization with Advanced Analytics
As more emerging pharma and biotech companies launch new drugs, a significant part of the battle is ensuring patient and provider education, accessibility, and engagement. A short timeline, a small budget, and the need to build analytical capabilities from the ground up creates a unique challenge. Dynamic market conditions and potential fast track approval by the FDA further add to the need for speed and agility. Early availability of advanced analytics is essential to reduce market risk and make the right decisions quickly.

Advancements in AI and cloud technologies have made it possible for pre-revenue companies with cost and resource constraints to be equipped with advanced analytics that were previously only available to big pharma organizations. There are many moving parts during the commercialization process and building a unified data-driven strategy is essential. Accessibility of unified data and analytics can provide a step change in an organization’s efforts to mitigate risks, lower costs and increase the likelihood of the product’s commercial success.

This discussion will provide real-world examples of using advanced analytics to solve the challenges faced during fast track drug launches. In addition, we will illustrate how efficiently advanced analytics can be deployed and managed with fewer resources.



Speakers
avatar for Mohamed Ladha

Mohamed Ladha

General Manager, US Business Unit, Oncopeptides
Mohamed Ladha was appointed General Manager, US Business Unit in September 2020 and leads the day-to-day operations and commercialization of the Oncopeptides Oncology portfolio for the US region. Before Mohamed joined Oncopeptides he spent over 17 years extensively in the fields of... Read More →
avatar for Janardan Prasad

Janardan Prasad

CBO & Head of Life Sciences, Lore IO
Janardan is a technology entrepreneur with 18 years of experience; the last decade driving innovation at early stage startups. He is passionate about technology enabling collaboration and shared economy. In his previous startups, he built India’s first wave of transportation and... Read More →


Tuesday January 12, 2021 11:30am - 12:00pm EST

12:00pm EST

Networking Break
Tuesday January 12, 2021 12:00pm - 1:00pm EST

1:00pm EST

Manufacturing innovation across new modalities
The successful outcomes delivered by cell and gene therapies coupled with emergence of modalities across nucleic acid therapeutics and microbiomes pose the next challenge for innovators to make these new modalities available at scale. Faster adoption of emerging cutting-edge development and manufacturing technologies will be vital to success and broad accessibility for patients. In this talk, we review and present key areas of technology innovation that have the potential to reshape how these advanced therapeutics are manufactured at scale.

Speakers
avatar for Julien Meissonnier

Julien Meissonnier

Vice President & Chief Scientific Officer, Catalent
Julien Meissonnier is part of Catalent’s executive leadership team heading up the company’s scientific community and customer advisory partnerships helping to improve formulation and adoption of new drug delivery technologies. He leads new product development and technology... Read More →


Tuesday January 12, 2021 1:00pm - 1:30pm EST

1:35pm EST

Executive Interview: Stéphane Bancel, Chief Executive Officer, Moderna
Moderator
avatar for Eric Sagonowksy

Eric Sagonowksy

Editor, Fierce Pharma
Eric Sagonowsky is an editor with the FierceMarkets Life Sciences team. Before joining Fierce in November 2014, Eric worked as a news reporter for the Manistee News Advocate in Manistee, Mich., covering government and crime issues. Eric graduated from Ohio University's E.W. Scripps... Read More →

Speakers
avatar for Stéphane Bancel

Stéphane Bancel

CEO, Moderna
Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna’s board of directors since March 2011. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA... Read More →


Tuesday January 12, 2021 1:35pm - 1:55pm EST

2:00pm EST

Biopharma production agility through orchestration
In trying to bring therapeutics and vaccines to market more efficiently, many manufacturers need to deal with legacy equipment.  Do you have “islands of automation” consisting of a variety of equipment and skids without an overarching supervisory system? As the need for speed and agility is greatly increasing, biopharma production facilities need some way to better visualize batch processing across various equipment and systems.

Orchestration can help achieve centralized recipe management, real-time visibility across the entire process, and batch reporting. This enables faster updates to existing facilities, and ramping up production of new biopharma products.



Speakers
avatar for Tiffany Barnes

Tiffany Barnes

Technical Solutions Consultant, Life Sciences and Specialty Chemicals, Honeywell
Tiffany Barnes is a Technical Solutions Consultant for Project Automation Solutions in Honeywell Process Solutions (HPS). She is based in Houston, TX and has over 10 years of experience with HPS working in projects implementing controls, procedural operations and HMI across various... Read More →


Tuesday January 12, 2021 2:00pm - 2:30pm EST

2:30pm EST

Networking Break
Tuesday January 12, 2021 2:30pm - 3:00pm EST

3:00pm EST

Executive Interview: Guido Seidel, Ph.D., Vice President Biopharma, WACKER Chemie
Moderator
avatar for Rebecca Willumson

Rebecca Willumson

Vice President & Publisher, Fierce Pharma & Fierce Healthcare
Rebecca Willumson is the Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of Fierce Biotech, Fierce Pharma and Fierce Healthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital publications... Read More →

Speakers
avatar for Guido Seidel, Ph.D.

Guido Seidel, Ph.D.

Managing Director, Wacker Biotech GmbH
Guido Seidel, Ph.D., has more than 20 years of experience in large-scale industrial biopharmaceutical production.  He joined WACKER in 2007 and is currently responsible as Vice President Biopharma at Wacker Chemie AG. In this position, he directs the business line BioPharma, which... Read More →


Tuesday January 12, 2021 3:00pm - 3:10pm EST

3:10pm EST

Executive Interview: Joe Jimenez, Co-Founder and Managing Director, Aditum Bio
Speakers
avatar for Amirah Al Idrus

Amirah Al Idrus

Editor, Fierce Biotech
avatar for Joe Jimenez

Joe Jimenez

Co-Founder and Managing Director, Aditum Bio
Joe Jimenez is Co-Founder and Managing Partner at Aditum Bio, a biotech venture firm.  From 2010 to 2018, Mr. Jimenez held the position of Chief Executive Officer (CEO) of Novartis, one of the world’s leading pharmaceutical companies. Under his leadership, Novartis developed... Read More →


Tuesday January 12, 2021 3:10pm - 3:30pm EST

3:30pm EST

Executive Interview: Martin Meeson, CEO Fujifilm Diosynth Biotechnologies
Moderator
avatar for Rebecca Willumson

Rebecca Willumson

Vice President & Publisher, Fierce Pharma & Fierce Healthcare
Rebecca Willumson is the Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of Fierce Biotech, Fierce Pharma and Fierce Healthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital publications... Read More →

Speakers
avatar for Martin Meeson

Martin Meeson

Chief Executive Officer, FUJIFILM Diosynth Biotechnologies
Martin Meeson is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets. Martin was named Chief Executive Officer on April 1st, 2020 after serving as Chief Operating Officer and President at of our US FDB operations (North Carolina... Read More →


Tuesday January 12, 2021 3:30pm - 3:45pm EST

3:45pm EST

Rerouting: How real-time patient data will drive the future of healthcare
There can be no mention in today’s clinical trial world without considering decentralised capabilities. The continued digitization of trials combined with the COVID-19 pandemic have thrust trials into new and unexplored pathways. Now, with several companies heralding the promise of real-time data, the industry may be about to take a sharp right turn. Join our speakers as they discuss key real-time data and decentralised trial principles from the patient journey and measures that matter to clinical research as a care option.


Moderator
avatar for Michelle Longmire, M.D.

Michelle Longmire, M.D.

CEO, Medable
Dr. Michelle Longmire is the founder and Chief Executive Officer of Medable. Dr. Longmire is mission driven to accelerate the development of new therapies for disease. As a Stanford-trained physician-scientist, Dr. Longmire identified critical barriers to drug development and founded Medable to... Read More →

Speakers
avatar for Dr. Priyanka Agarwal

Dr. Priyanka Agarwal

Director and Head of Digital Health, Myokardia/BMS
Dr. Priyanka Agarwal, MD, MBA is the Director and Head of Digital Health at MyoKardia, now part of Bristol Myers Squibb, and Associate Clinical Professor of Medicine in the Division of Hospital Medicine at the University of California, at San Francisco (UCSF). At MyoKardia, Dr. Agarwal... Read More →
avatar for Andy Coravos

Andy Coravos

Co-founder and CEO, Elektra Labs
Andy Coravos (@andreacoravos) is the CEO/co-founder of Elektra Labs, building a digital medicine platform focusing on digital biomarkers for decentralized clinical trials. She serves as a research collaborator at the Harvard-MIT Center for Regulatory Sciences. Formerly, she serve... Read More →
avatar for Maria Fotiu

Maria Fotiu

Executive VP of Decentralized Solutions, Syneos
Maria Fotiu, EVP Decentralized Solutions is based in Raleigh, NC and has over 25 years of industry experience in clinical trials execution and delivery.  Ms. Fotiu has led global functions and directed large pharma partnerships throughout her career.  In her most recent role, she... Read More →
avatar for Thomas Switzer

Thomas Switzer

Digital Health Scientist, Genentech
Tom is a Digital Health Scientist in Genentech's Research and Early Development Informatics Digital Transformation Office. His current focus is on developing technology platforms supporting molecule teams across the Genentech early development portfolio. Tom has over 20 years of clinical... Read More →


Tuesday January 12, 2021 3:45pm - 4:15pm EST

4:15pm EST

Executive Interview: George Scangos, CEO, Vir
Speakers
avatar for Arlene Weintraub

Arlene Weintraub

Contributing Writer, Fierce Biotech
Arlene Weintraub has over 15 years of experience writing about health care, pharmaceuticals and biotechnology. Her freelance pieces have been published in the New York Times, US News & World Report, Technology Review, Scientific American, USA Today, Entrepreneur.com, FierceMarkets... Read More →
avatar for George Scangos, Ph.D.

George Scangos, Ph.D.

CEO and President, Vir
 George Scangos, Ph.D., has served Vir’s President and Chief Executive Officer and as a member of our board of directors since January 2017. From July 2010 to December 2016, Dr. Scangos served as Chief Executive Officer and as a member of the board of directors of Biogen Inc... Read More →


Tuesday January 12, 2021 4:15pm - 4:45pm EST
 
Wednesday, January 13
 

9:30am EST

Open for Networking
Wednesday January 13, 2021 9:30am - 10:00am EST

10:00am EST

The last mile: How will a COVID-19 vaccine make it from plant to patients?
Once a COVID-19 vaccine becomes available, it faces a number of logistic hurdles in making it to patients. Those hurdles include figuring out the best distribution channels, coming up with the most ethical and effective prioritization of distribution, convincing patients of its safety and, of course, figuring out who's going to pay for it all. We talk to the companies that are at the heart of making all this happen to better understand the challenges, questions and opportunities at play as the system prepares for the release of a COVID-19 vaccine.

Moderator
avatar for Tina Reed

Tina Reed

Executive Editor, Fierce Healthcare
Tina Reed oversees Fierce Healthcare and all of its publications.  Tina has been reporting on healthcare for more than a decade and her work has appeared in Fierce Healthcare, the Washington Business Journal, the Capital Gazette, AnnArbor.com, The Ann Arbor News and the Las Vegas... Read More →

Speakers
avatar for Chris Cox

Chris Cox

Senior Vice President of Pharmacy, CVS Health
Chris Cox is Senior Vice President of Pharmacy for CVS Health. He has been leading CVS Health's efforts to administer COVID-19 vaccines and serves as the company's liaison to Operation Warp Speed.  
avatar for J. Stephen Jones, MD

J. Stephen Jones, MD

President and CEO, Inova Health System
J. Stephen Jones, MD, is President and CEO of Inova, the Washington, DC region’s leading not-for-profit healthcare system serving more than 2 million people annually in its five hospitals and numerous ambulatory programs. He is also Professor of Urology at the University of Virginia... Read More →
avatar for Heather Zenk, RPh, PharmD

Heather Zenk, RPh, PharmD

SVP of Strategic Global Sourcing, AmerisourceBergen
Heather Zenk, RPh, PharmD, has responsibilities for developing and implementing traceability business processes and technology that will enhance patient safety, further secure the pharmaceutical supply chain and create broader service offerings to manufacturer partners and AmerisourceBergen... Read More →
avatar for Rick Gates

Rick Gates

Senior Vice President – Pharmacy and Healthcare, Walgreens
Rick Gates is senior vice president of pharmacy and healthcare at Walgreens, based in Deerfield Ill.  He is responsible for commercial development and sales, contracting, pharma development, pharmacy supply chain, and clinical programs and alliances.   Before then he was group... Read More →


Wednesday January 13, 2021 10:00am - 11:00am EST

11:00am EST

Executive Interview: Reed Tuckson, M.D., Founder, Black Coalition Against Covid (BCAC)
Moderator
avatar for Jim Weiss

Jim Weiss

Founder and Chief Executive Officer, W2O
Jim Weiss is the founder and chief executive officer of W2O, the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. Over the years, Jim has often been recognized as one of the most influential people in health communications... Read More →

Speakers
avatar for Reed V. Tuckson, M.D., FACP

Reed V. Tuckson, M.D., FACP

Tuckson Health Connections, LLC
Reed V. Tuckson, MD, FACP, is Managing Director of Tuckson Health Connections, LLC, a vehicle to advance initiatives that support optimal health and wellbeing through the intersection of individual and community health promotion and disease prevention; applied data and analytics... Read More →


Wednesday January 13, 2021 11:00am - 11:35am EST

11:35am EST

Executive Interview: Vivian Lee, President of Health Platforms, Verily Life Sciences
Moderator
avatar for Heather Landi

Heather Landi

Senior Editor, Fierce HealthIT

Speakers
avatar for Vivian Lee

Vivian Lee

President of Health Platforms, Verily Life Sciences
Vivian S. Lee, M.D., Ph.D., M.B.A., is the author of The Long Fix: Solving America's Health Care Crisis with Strategies that Work for Everyone. She is President of Health Platforms at Verily Life Sciences. Before joining Verily, Dr. Lee served as Dean of the Medical School and CEO of University of Utah Health Care, an integrated health system with a budget of $3.6 billion. Prior to Utah, she was the Chief Scientific Officer o... Read More →


Wednesday January 13, 2021 11:35am - 11:50am EST

11:50am EST

Challenge the Rules of Security: Transform the Threat Surface to Proactive Control
We’ve seen a dramatic increase in distributed workforce, telehealth and usage of cloud applications across healthcare providers. And healthcare organizations continue to be targeted by cybercriminals, and now with remote endpoints, they have more ways to break in than ever before. Historically, endpoint security has been a zero-sum game—with the odds inevitably stacked against IT. But rather than protecting devices, what if you could control their security ahead of time?\

In this session, see how Chrome OS and Chrome Browser are secure by design—embedding security into every workflow to provide proactive protection for your staff, devices, applications, and patient information, wherever work happens. This is cloud-first security that will help healthcare providers thrive moving forward.

Speakers
avatar for Mike Puzen

Mike Puzen

Market Manager, Chrome Enterprise, Google
Mike has been a technology thought leader for the past 15 years.  He has focused on Retail, Manufacturing and Healthcare for most of his career with IBM, Sandisk, Lenovo and now Google. The goal for him as always been to push the boundaries of innovation at the customer experience... Read More →


Wednesday January 13, 2021 11:50am - 12:00pm EST

12:00pm EST

Networking Break
Wednesday January 13, 2021 12:00pm - 1:00pm EST

1:00pm EST

Clinical molecular modeling of COVID-19: The decoding of the viral disease with its many faces
In the light of the COVID 19 pandemic, a comprehensive understanding of COVID 19 and the underlying core molecular mechanisms which control and determine the individual host response is urgently warranted.

To this end, an evidence-based, holistic, precision-medicine approach is required. Molecular Health established an integrated disease-modeling processes — augmented by state-of-the-art data capture, curation, and analysis — to map the totality of fundamental mechanisms involved in COVID 19. Using our Dataome platform, we built a comprehensive COVID 19 disease model that links key molecular players of COVID 19 pathophysiology to disease symptoms, severe manifestations and outcome, or severity-associated risk factors. Our model revealed that the multitude of seemingly disparate clinical phenotypes can largely be linked to the pleiotropic activity of a few core molecular players and mechanisms involved in the host response, thereby offering an in toto approach to decoding the disease. Within six weeks, we generated a current, inclusive atlas of COVID 19 pathogenesis, with potentially significant implications on the development of diagnostic and therapeutic strategies. This project demonstrates the utility of our Dataome platform in decoding complex diseases.



Speakers
avatar for Stephan Brock, Ph.D.

Stephan Brock, Ph.D.

Chief Technology Officer and Co-Founder, Molecular Health
Dr. Brock has worked in several leading positions in the bioinformatics  industry focusing on data integration, text-mining, and content management supporting the pharmaceutical R&D value chain.  As head of development and CEO of Metalife AG, Dr. Brock led a team of 70 analysts... Read More →


Wednesday January 13, 2021 1:00pm - 1:30pm EST

1:30pm EST

Executive Interview: Tim Wentworth, CEO of Cigna's Evernorth
Moderator
avatar for Paige Minemyer

Paige Minemyer

Senior Editor, Fierce Healthcare
Paige Minemyer is a senior editor at Fierce Healthcare, overseeing the team’s coverage of payer trends and news from across the country. Since joining the Fierce team, she’s covered the spectrum of the healthcare industry, including providers, technology and policy, and prior... Read More →

Speakers
avatar for Tim Wentworth

Tim Wentworth

CEO, Cigna's Evernorth
Tim Wentworth serves as the Chief Executive Officer of Evernorth. Prior to this role, Wentworth served as President, Express Scripts and Cigna Services. Prior to the Cigna/Express Scripts combination in 2018, Wentworth served as President and CEO of Express Scripts, where he was responsible... Read More →


Wednesday January 13, 2021 1:30pm - 1:50pm EST

1:50pm EST

Executive Interview: Arif Nathoo, M.D., CEO and Co-Founder, Komodo Health
Moderator
avatar for Rebecca Willumson

Rebecca Willumson

Vice President & Publisher, Fierce Pharma & Fierce Healthcare
Rebecca Willumson is the Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of Fierce Biotech, Fierce Pharma and Fierce Healthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital publications... Read More →

Speakers
avatar for Arif Nathoo, M.D.

Arif Nathoo, M.D.

Co-Founder and CEO, Komodo Health
Arif Nathoo, MD, is Co-Founder and Chief Executive Officer at Komodo Health where he oversees data sciences, engineering, and product development initiatives for the company. He has spent the past 15 years in healthcare and life sciences leadership roles. Before Komodo Health, Arif... Read More →


Wednesday January 13, 2021 1:50pm - 2:00pm EST

2:30pm EST

Networking Break
Wednesday January 13, 2021 2:30pm - 3:00pm EST

3:00pm EST

Executive Interview: Halee Fischer-Wright, M.D., President and CEO, Medical Group Management Association (MGMA)
Moderator
avatar for Tina Reed

Tina Reed

Executive Editor, Fierce Healthcare
Tina Reed oversees Fierce Healthcare and all of its publications.  Tina has been reporting on healthcare for more than a decade and her work has appeared in Fierce Healthcare, the Washington Business Journal, the Capital Gazette, AnnArbor.com, The Ann Arbor News and the Las Vegas... Read More →

Speakers
avatar for Halee Fischer-Wright, M.D.

Halee Fischer-Wright, M.D.

President and CEO, Medical Group Management Association (MGMA)
Halee Fischer-Wright, M.D., is a member of FierceHealthcare Editorial Advisory Council. She is the president and CEO of the Medical Group Management Association (MGMA), a national organization that has been leading change in the business of healthcare and medical practice management... Read More →


Wednesday January 13, 2021 3:00pm - 3:20pm EST

3:20pm EST

Executive Interview: Jim Weiss, Founder and CEO, W2O
Moderator
avatar for Rebecca Willumson

Rebecca Willumson

Vice President & Publisher, Fierce Pharma & Fierce Healthcare
Rebecca Willumson is the Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of Fierce Biotech, Fierce Pharma and Fierce Healthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital publications... Read More →

Speakers
avatar for Jim Weiss

Jim Weiss

Founder and Chief Executive Officer, W2O
Jim Weiss is the founder and chief executive officer of W2O, the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. Over the years, Jim has often been recognized as one of the most influential people in health communications... Read More →


Wednesday January 13, 2021 3:20pm - 3:35pm EST

3:35pm EST

Executive Interview: John Potthoff, Ph.D., CEO, Elligo
Speakers
avatar for Rebecca Willumson

Rebecca Willumson

Vice President & Publisher, Fierce Pharma & Fierce Healthcare
Rebecca Willumson is the Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of Fierce Biotech, Fierce Pharma and Fierce Healthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital publications... Read More →
avatar for John Potthoff, Ph.D.

John Potthoff, Ph.D.

CEO, Elligo
A respected veteran with nearly 25 years in the clinical research services industry, John Potthoff, Ph.D., has directed major business for a number of companies. Potthoff’s career began with a series of executive roles involving increasing responsibility at PPD. After seven... Read More →


Wednesday January 13, 2021 3:35pm - 3:45pm EST

3:45pm EST

Executive Interview: David Feinberg, M.D., Vice President of Google Health
Moderator
avatar for Heather Landi

Heather Landi

Senior Editor, Fierce HealthIT

Speakers
avatar for David Feinberg, M.D.

David Feinberg, M.D.

Vice President, Google Health
David Feinberg currently heads up Google’s health efforts. Previously, David was President & CEO of Geisinger, one of the nation’s most innovative health services organizations. While at Geisinger, David oversaw 13 hospital campuses, a 600,000-member health plan, research centers... Read More →


Wednesday January 13, 2021 3:45pm - 4:00pm EST
 
  • Timezone
  • Filter By Date Fierce Virtual Series: JPM Week 2021 Jan 11 -13, 2021
  • Filter By Type
  • Interviews
  • Keynote
  • Networking
  • Panel Discussions
  • Presentations